Zhang, Yuezhou https://orcid.org/0000-0003-4817-3835
Pratap, Abhishek https://orcid.org/0000-0002-5289-6932
Folarin, Amos A. https://orcid.org/0000-0002-0333-1927
Sun, Shaoxiong https://orcid.org/0000-0003-3652-5266
Cummins, Nicholas https://orcid.org/0000-0002-1178-917X
Matcham, Faith
Vairavan, Srinivasan https://orcid.org/0000-0001-7975-8436
Dineley, Judith
Ranjan, Yatharth https://orcid.org/0000-0003-3079-3120
Rashid, Zulqarnain
Conde, Pauline
Stewart, Callum
White, Katie M.
Oetzmann, Carolin https://orcid.org/0000-0003-1480-917X
Ivan, Alina
Lamers, Femke
Siddi, Sara
Rambla, Carla Hernández https://orcid.org/0000-0002-4491-3018
Simblett, Sara https://orcid.org/0000-0002-8075-8238
Nica, Raluca
Mohr, David C. https://orcid.org/0000-0002-5443-7596
Myin-Germeys, Inez
Wykes, Til https://orcid.org/0000-0002-5881-8003
Haro, Josep Maria
Penninx, Brenda W. J. H.
Annas, Peter https://orcid.org/0000-0003-0576-765X
Narayan, Vaibhav A.
Hotopf, Matthew
Dobson, Richard J. B. https://orcid.org/0000-0003-4224-9245
,
Funding for this research was provided by:
Innovative Medicines Initiative (115902, 115902)
Article History
Received: 27 April 2022
Accepted: 10 January 2023
First Online: 17 February 2023
Competing interests
: S.V. and V.A.N. are employees of Janssen Research and Development LLC. P.A. is employed by the pharmaceutical company H. Lundbeck A/S. D.C.M. has accepted honoraria and consulting fees from Apple Inc, Otsuka Pharmaceuticals, Pear Therapeutics, and the One Mind Foundation; has received royalties from Oxford Press; and has an ownership interest in Adaptive Health Inc. M.H. is the principal investigator of the Remote Assessment of Disease and Relapse–Central Nervous System project, a private public precompetitive consortium that receives funding from Janssen, UCB, Lundbeck, MSD, and Biogen. C.O. is supported by the UK Medical Research Council (MR/N013700/1) and King’s College London, member of the MRC Doctoral Training Partnership in Biomedical Sciences. All other authors declare no competing interests.